[Clinical studies on the urinary excretion of aldosterone in myasthenia gravis].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000328:Adult; D000450:Aldosterone / Q000652:urine*; D000549:Ambenonium Chloride / Q000652:urine; D002395:Catecholamines / Q000652:urine; D002845:Chromatography; D002854:Chromatography, Paper; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000652:urine*; D009640:Norethindrone / Q000652:urine; D011188:Potassium / Q000097:blood / Q000652:urine; D012964:Sodium / Q000097:blood / Q000652:urine; D013057:Spectrum Analysis; D013148:Spironolactone / Q000652:urine; D014223:Triamterene / Q000652:urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D002395:Catecholamines; D013148:Spironolactone; D000450:Aldosterone; D000549:Ambenonium Chloride; D012964:Sodium; D011188:Potassium; D009640:Norethindrone; D014223:Triamterene